Webinar: What Practitioners Should Know About PEA

Dear Colleague,

Many of you have asked me for detailed insights on treating chronic fatigue syndrome and fibromyalgia. I’m excited to share a promising new treatment option with you.

Hundreds of studies confirm that PEA (Palmitoylethanolamide) is remarkably effective for chronic pain relief. However, until now, poor absorption has limited its full potential. I'm happy to say that challenge has been solved. EuroMedica® has developed a new PEA formulation using a proprietary absorption-enhancing system called GammaSorb®, allowing for much better bioavailability.

PEA not only addresses chronic pain and central sensitization, which are common in nearly all types of pain, but also significantly reduces MCAS and sensitivities while improving overall symptoms. EuroMedica's new product, PEA Healthy Inflammation Response, is now a key recommendation in my chronic pain discussions.

My suggested protocol is 600 mg twice daily for one month, followed by 1,200 mg twice daily for two months. This three-month regimen serves as a fair therapeutic trial, and in many cases, dramatic improvements occur within a week or two. One patient, previously housebound due to fibromyalgia, saw rapid improvement and is now able to travel comfortably through Peru.

We now have an effective, natural way to target the three key components of chronic pain:

1. Myofascial muscle pain
2. Inflammatory pain and now
3. Brain pain/microglial activation

I invite you to join my free webinar for this important discussion. Register below to secure your spot.

WHEN: Thursday, April 17th at 1:00 PM Central

Love and Blessings,
Jacob